Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study
Related Posts
Hamashima R, Tashiro M, Nakano Y, Shirahige T, Namie H, Yano H, Ito Y, Yoshida M, Hirayama T, Takeda K, Iwanaga N, Kakiuchi S, Nishi[...]
Dong S, Harris C, Ly A, Lee PS. Doxycycline-Induced Phototoxicity Localized to Vitiligo-Affected and Sun-Exposed Skin. Cureus. 2026 Feb 17;18(2):e103789. doi: 10.7759/cureus.103789. PMID: 41869147; PMCID:[...]
de Vos L, Rutt K, Metula A, Peters RPH, Bongo C, Daniels J. "It's being uncomfortable for who you are, because I think HIV is[...]